News & Events

October 03, 2021

Study Shows Oxidative Stress and Impaired Methylation are Hallmarks of ASD

Building upon a previous study which demonstrated that gene expression of B12 and folate-dependent enzyme methionine synthase was lower in individuals with autism, a new study has shown that oxidative stress (i.e. low antioxidant levels) and impaired methylation are telltale signs of autism.

September 26, 2021

Community Shares | September 28, 2021

An expert panel of child neuropsychiatry and sleep specialists have developed practice tools for screening and monitoring insomnia for children and adolescents with ASD. They recommend insomnia screenings for all children with autism and referring to a sleep specialist if a comorbid sleep disorder is suspected.   Sen. Sherrod Brown, D-Ohio, has introduced a bill that […]

September 26, 2021

Autism Glossary: What Terms Are Acceptable in the ASD Community?

NBC’s Today Show recently entered into the fray of preferred autism-related terminology. In an earlier report,  the morning news show suggested that there is a war between parents of children with autism and autistic adults about how the condition should be viewed.

September 26, 2021

Disaster Preparedness for People with Disabilities

Emergencies and disasters happen in unpredictable ways and in some instances, with no advanced warning. These unexpected situations are challenging for everyone, but can be especially difficult for individuals with special needs and their caregivers. Which is why disaster preparedness is critical for the disability community.

September 16, 2021

Community Shares | Sept 21st

A new study implicates altered hippocampal structure and function in autism spectrum disorder. Social interaction, spatial reasoning, and memory are supported by the hippocampus, which is also impaired in those with ASD. The critical window of development for the hippocampus is between 12 and 24 months, the same time symptoms of autism typically emerge.  Iron […]

September 16, 2021

Bumetanide Fails Phase 3 Trials

Bumetanide is a generically-available diuretic drug used to treat high blood pressure.  For years, the medication was thought to have potential for treating autism due to its effect on the GABA neurotransmitter pathway, which is speculated to be disrupted in autism.

Show Buttons
Hide Buttons